Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Hyper-CVAD chemotherapy or autologous stem cell transplantation in patients with peripheral T cell lymphomas: a single centre report.

Xu Y, Wu XJ, Wang Y, Jin ZM, Sun AN, Wu DP.

Chin Med J (Engl). 2012 Nov;125(22):4134-7.

PMID:
23158157
2.

Prognostic factors and clinical outcomes of high-dose chemotherapy followed by autologous stem cell transplantation in patients with peripheral T cell lymphoma, unspecified: complete remission at transplantation and the prognostic index of peripheral T cell lymphoma are the major factors predictive of outcome.

Yang DH, Kim WS, Kim SJ, Bae SH, Kim SH, Kim IH, Yoon SS, Mun YC, Shin HJ, Chae YS, Kwak JY, Kim H, Kim MK, Kim JS, Won JH, Lee JJ, Suh CW.

Biol Blood Marrow Transplant. 2009 Jan;15(1):118-25. doi: 10.1016/j.bbmt.2008.11.010.

3.

High-dose therapy and autologous stem cell transplantation in peripheral T-cell lymphoma: treatment outcome and prognostic factor analysis.

Gui L, Shi YK, He XH, Lei YH, Zhang HZ, Han XH, Zhou SY, Liu P, Yang JL, Dong M, Zhang CG, Yang S, Qin Y.

Int J Hematol. 2014 Jan;99(1):69-78. doi: 10.1007/s12185-013-1465-y. Epub 2013 Nov 21.

PMID:
24258711
4.

High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.

Kim MK, Kim S, Lee SS, Sym SJ, Lee DH, Jang S, Park CJ, Chi HS, Huh J, Suh C.

Ann Hematol. 2007 Jun;86(6):435-42. Epub 2007 Jan 26.

PMID:
17256144
5.

Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantation.

Jeong SH, Moon JH, Kim JS, Yang DH, Park Y, Cho SG, Kwak JY, Eom HS, Won JH, Hong JS, Oh SY, Lee HS, Kim SJ.

Ann Hematol. 2015 Apr;94(4):617-25. doi: 10.1007/s00277-014-2258-y. Epub 2014 Dec 3.

PMID:
25465233
6.

Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.

d'Amore F, Relander T, Lauritzsen GF, Jantunen E, Hagberg H, Anderson H, Holte H, Österborg A, Merup M, Brown P, Kuittinen O, Erlanson M, Østenstad B, Fagerli UM, Gadeberg OV, Sundström C, Delabie J, Ralfkiaer E, Vornanen M, Toldbod HE.

J Clin Oncol. 2012 Sep 1;30(25):3093-9. doi: 10.1200/JCO.2011.40.2719. Epub 2012 Jul 30.

PMID:
22851556
7.

Efficacy of a dose-intensified CHOP (Double-CHOP) regimen for peripheral T-cell lymphomas.

Iriyama N, Takahashi H, Hatta Y, Miura K, Kobayashi Y, Kurita D, Hirabayashi Y, Hojo A, Kodaira H, Yagi M, Kiso S, Uchino Y, Nakagawa M, Kusuda M, Kobayashi S, Horikoshi A, Kura Y, Yamazaki T, Sawada U, Takeuchi J.

Oncol Rep. 2013 Feb;29(2):805-11. doi: 10.3892/or.2012.2143. Epub 2012 Nov 15.

PMID:
23166041
8.

Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial.

Ahn JS, Yang DH, Jung SH, Chae YS, Sohn SK, Yhim HY, Kwak JY, Lee SR, Kim YK, Kim HJ, Lee JJ.

Ann Hematol. 2013 Jun;92(6):789-97. doi: 10.1007/s00277-013-1685-5. Epub 2013 Jan 29.

PMID:
23358616
9.

High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience.

Rodriguez J, Caballero MD, Gutierrez A, Gandarillas M, Sierra J, Lopez-Guillermo A, Sureda A, Zuazu J, Marin J, Arranz R, Carreras E, Leon A, De Sevilla AF, San Miguel JF, Conde E; GEL/TAMO Spanish Group.

Haematologica. 2003 Dec;88(12):1372-7.

10.

Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry.

Ellin F, Landström J, Jerkeman M, Relander T.

Blood. 2014 Sep 4;124(10):1570-7. doi: 10.1182/blood-2014-04-573089. Epub 2014 Jul 8.

11.

Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: A single-centre experience.

Han X, Zhang W, Zhou D, Ruan J, Duan M, Zhu T, Li J, Cai H, Cao X, Ouyang M.

J Int Med Res. 2017 Feb;45(1):290-302. doi: 10.1177/0300060516676725. Epub 2017 Jan 12.

12.

Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas.

Niitsu N, Okamoto M, Nakamine H, Aoki S, Motomura S, Hirano M.

Hematol Oncol. 2008 Sep;26(3):152-8. doi: 10.1002/hon.853.

PMID:
18395866
13.

Comparison of clinical outcome after autologous stem cell transplantation between patients with peripheral T-cell lymphomas and diffuse large B-cell lymphoma.

Sohn BS, Park I, Kim EK, Yoon DH, Lee SS, Kang BW, Jang G, Choi YH, Kim C, Lee DH, Kim S, Huh J, Suh C.

Bone Marrow Transplant. 2009 Sep;44(5):287-93. doi: 10.1038/bmt.2009.29. Epub 2009 Feb 23.

PMID:
19234508
14.

DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.

Mikesch JH, Kuhlmann M, Demant A, Krug U, Thoennissen GB, Schmidt E, Kessler T, Schliemann C, Pohlen M, Mohr M, Evers G, Köhler G, Wessling J, Mesters R, Müller-Tidow C, Berdel WE, Thoennissen NH.

Ann Hematol. 2013 Aug;92(8):1041-8. doi: 10.1007/s00277-013-1738-9. Epub 2013 Mar 27.

PMID:
23532626
15.

Prolonged survival of patients with peripheral T-cell lymphoma after first-line intensive sequential chemotherapy with autologous stem cell transplantation.

Prochazka V, Faber E, Raida L, Vondrakova J, Kucerova L, Jarosova M, Indrak K, Papajik T.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009 Mar;153(1):63-6.

16.

High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas.

Blystad AK, Enblad G, Kvaløy S, Berglund A, Delabie J, Holte H, Carlson K, Kvalheim G, Bengtsson M, Hagberg H.

Bone Marrow Transplant. 2001 Apr;27(7):711-6.

17.
19.

Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation.

Kahl C, Leithäuser M, Wolff D, Steiner B, Hartung G, Casper J, Freund M.

Ann Hematol. 2002 Nov;81(11):646-50. Epub 2002 Nov 9.

PMID:
12454703
20.

A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remission.

Mehta N, Maragulia JC, Moskowitz A, Hamlin PA, Lunning MA, Moskowitz CH, Zelenetz A, Matasar MJ, Sauter C, Goldberg J, Horwitz SM.

Clin Lymphoma Myeloma Leuk. 2013 Dec;13(6):664-70. doi: 10.1016/j.clml.2013.07.005. Epub 2013 Sep 11.

PMID:
24035712

Supplemental Content

Support Center